Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NUTX · against 452 other Healthcare companies of similar size
Ranked #14 of 453 · scores higher than 96% of peers
Bars: peers in each 10-point band of the valuation score47 peers with a valuation score of 90–100, including NUTX · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | NUTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 443 reported | 14.1% | 1.4% | 98% | 30% | |
| EBITDA yieldHigher is better · 456 reported | 33.8% | 4.3% | 99% | 50% | |
| Free cash flow yieldHigher is better · 205 reported | 22.3% | -1.6% | 99% | 20% | |
| Book yieldHigher is better · 448 reported | 32.1% | 40.9% | 38% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 8 | 2.0B EUR (≈$2.1B) | 97 | 67 | |
| 14 | 285.2B JPY (≈$1.9B) | 96 | 65 | |
| 14 | 810M USD | 96 | 69 | |
| 14 | 2.1B USD | 96 | 96 | |
| 14 | 1.2B USD | 96 | 75 | |
| 14 | 15.6B DKK (≈$2.3B) | 96 | 96 | |
| 19 | 6.6B HKD (≈$840M) | 95 | 71 | |
| 19 | 7.1B CNY (≈$994M) | 95 | 54 | |
| 19 | 109.3B JPY (≈$743M) | 95 | 76 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score